Evaluation of the effectiveness of whole body vibration training in healthy untrained females

Not Applicable

Completed

• Conditions: Musculoskeletal function; Hemorheological properties of blood; Cognitive function; Musculoskeletal - Normal musculoskeletal and cartilage development and function; Blood - Normal development and function of platelets and erythrocytes; Mental Health - Studies of normal psychology, cognitive function and behaviour

• Registration Number: ACTRN12621000114842
• Lead Sponsor: Halina Gattner

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-06-28
• Study Start: 2021-02-04
• Last Update Posted: 8 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 46

Inclusion Criteria

No contraindications to whole body vibration training
Female aged 18-25
Non-training people or with low level of physical activity
Similar eating habits
BMI 18,5–24,99
Giving informed written consent

Exclusion Criteria

Lack of logical contact with the patient
Declaration of undertaking increased physical activity within 1 month before starting the study
Smoking tobacco
Regular intake of antioxidant vitamins and other dietary supplements at least 1 month before the start of the study
Use of hormonal contraceptives
Diagnosed with polycystic ovary syndrome or anovulatory cycles
Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of changes in rheological properties of blood such as the erythrocyte elongation index (EI), erythrocyte aggregation indexes (AI), i.e. AMP - total aggregation, T1/2 - half time of total aggregation and fibrinogen which were determined using Analizator Laser-assisted Optical Rotational Cell Analyser (LORCA) RR Mechatronics.[Baseline, after 1 WBV (whole body vibration) training, before last WBV training and after last WBV training (12 weeks after intervention commencement)];Assessment of lower limb explosive performance capacity using a dynamometric platform (AMTI)[Baseline, 12 weeks after intervention commencement];Assessment of the basic plasma level of brain-derived neurotrophic factor (BDNF) in blood serum by enzyme-linked immunosorbent method (ELISA) using high-sensitivity reagent kits from DRG Instruments Gmbh (Germany) and SunRed Bio (China).[Baseline, after 1 WBV (whole body vibration) training, before last WBV training and after last WBV training (12 weeks after intervention commencement)]